Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 366 (9487), 733-741
- https://doi.org/10.1016/s0140-6736(05)66996-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantationBone Marrow Transplantation, 1997
- IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEBritish Journal of Haematology, 1997
- A PARTIALLY GROUPED LOGRANK TESTStatistics in Medicine, 1997
- Unrelated marrow donor registriesCurrent Opinion in Hematology, 1997
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramThe New England Journal of Medicine, 1993
- Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trialBlood, 1990
- Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantationBlood, 1986
- PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATIONThe Lancet, 1982
- Transplantation of Marrow from an Unrelated Donor to a Patient with Acute LeukemiaThe New England Journal of Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958